The Board of Directors of Chengdu Easton Biopharmaceuticals Co., Ltd. has authorized a buyback plan on August 14, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
56.24 CNY | +0.43% | -1.75% | -11.82% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.82% | 920M | |
+37.58% | 727B | |
-7.89% | 354B | |
+15.61% | 328B | |
-0.50% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.83% | 164B | |
-2.07% | 164B |
- Stock Market
- Equities
- 688513 Stock
- News Chengdu Easton Biopharmaceuticals Co., Ltd.
- Chengdu Easton Biopharmaceuticals Co., Ltd. authorizes a Buyback Plan.